Loading clinical trials...

Lap-Band Surgery on Adolescents for Safety and Efficacy | Clinical Trials | Clareo Health

COMPLETEDNA

Lap-Band Surgery on Adolescents for Safety and Efficacy

A Prospective, Open-label Study to Evaluate the Safety and Efficacy of Lap-Band® Adjustable Gastric Band (LAGB®) Operations in the Treatment of Morbidly Obese Adolescents (Ages 14-17)

NCT00587301•NYU Langone Health

View on ClinicalTrials.gov

Summary

This study is to demonstrate the safety and efficacy of the use of the LAP-BAND surgery in the morbidly obese adolescent population.

Detailed Description

STUDY OBJECTIVES: Is to demonstrate the safety and efficacy of the use of the LAP-BAND® System in the morbidly obese adolescent population in the United States, and therefore provide these individuals with a significantly less morbid and reversible surgical option for weight loss. STUDY VARIABLES:The primary efficacy variable is weight loss evaluated in terms of % excess weight loss (EWL). DESIGN:Prospective, open-label, and single center

Eligibility

Age

14 - 17 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Be at least 14 and less than 18 years of age at the time of enrollment into the study.
•Have a BMI of at least 40
•Have a history of obesity for at least 5 years, including failed attempts at diet and medical management of obesity.
•Confirmation by a psychologist or psychiatrist experienced with adolescents that the subject is sufficiently mature emotionally to comply with the study protocol.
•Express willingness to follow protocol requirements.
•Assure investigators that subject, if female of childbearing potential, is using an appropriate form of contraception.

Exclusion Criteria

•Intention or need to have another surgical procedure for weight reduction within 12 months of Lap Band placement.
•History of congenital or acquired anomalies of the G.I. tract, such as; congenital or acquired intestinal telangiectasia, Crohn's disease or ulcerative colitis; severe cardiopulmonary disease or severe coagulopathy; hepatic insufficiency or cirrhosis.
•Presence of dysphagia or documented esophageal dysmotility.
•Patients with autoimmune connective tissue disorders
•Patients with acute abdominal infections
•Pregnancy or intention of becoming pregnant in the next 12 months.
•Presence of psychiatric problems or immaturity which would compromise cooperation with the study protocol.
•History of previous bariatric surgery, intestinal obstruction or adhesive peritonitis.
•Presence of localized or systemic infection at the time of surgery.
•Chronic use of aspirin and/or non-steroidal anti-inflammatory medications and unwillingness to discontinue the use of these concomitant medications.
+2 more criteria

Locations (1)

New York University School of Medicine

New York, New York, United States

Key Dates

Start Date

June 1, 2005

Primary Completion Date

July 8, 2020

Completion Date

July 8, 2020

Last Updated

March 22, 2022

Enrollment

119

ACTUAL participants

Conditions

ObesityDM

Interventions

Lap-Band

DEVICE

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT01143454

Metabolic DiseaseObesity+4 more

View study

RECRUITINGNA

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 22, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Lap-Band Surgery on Adolescents for Safety and Efficacy

Inclusion Criteria

Exclusion Criteria

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Feasibility of a Tailored Online Self-compassion Intervention

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial

Protein Supplementation Intervention on Body Weight

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose